EGFR expression in colorectal cancer
This article has no abstract so we have provided the first paragraph of the full text.
There is strong evidence that epidermal growth factor receptor (EGFR) plays a role in tumor progression. A new study by Spano et al. has examined the relationship between EGFR expression, clinicohistological characteristics and survival in patients with colorectal cancer. Although EFGR was not shown to be an independent prognostic variable, overexpression of the protein was significantly associated with tumor stage.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.